3rd Annual Atlanta Precision Oncology Symposium

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

3rd Annual Atlanta Precision Oncology Symposium

Videos
Event

Playback speed

10 seconds

Targeted Therapy for Advanced NSCLC: Efficacy Analysis of RET, KRAS, HER2 & BRAF Targeting Agents

By 3rd Annual Atlanta Precision Oncology Symposium FEATURING Hossein Borghaei

35 views

March 7, 2021

Comments 0

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Videos

Genotype-Directed Therapy for Advanced NSCLC: Overview of Targeted T…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

539 views

Targeted Therapies for Advanced Urothelial Cancer: Erdafitinib for P…

3rd Annual Atlanta Precision Oncology Symposium

D. Petrylak

146 views

Targeted Therapy for Advanced NSCLC: Efficacy Analysis of RET, KRAS,…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

35 views

2021 Expert Discussion on GU Cancers: Should We Use Olaparib Before …

3rd Annual Atlanta Precision Oncology Symposium

E. Antonarakis, D. Petrylak, T. Zhang

233 views

Treatment of DNA Repair-Deficient Advanced Prostate Cancer

3rd Annual Atlanta Precision Oncology Symposium

E. Antonarakis

241 views

2021 Expert Discussion on Advanced NSCLC: Is Osimertinib a Good Sequ…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon, N. Hanna, H. Borghaei, J. Kirkpatrick

390 views

Early Detection of Lung Cancer: Molecular Enrichment Strategy

3rd Annual Atlanta Precision Oncology Symposium

J. Kirkpatrick

95 views

Selecting Systemic First-Line Treatment in Stage IV NSCLC Without Dr…

3rd Annual Atlanta Precision Oncology Symposium

N. Hanna

324 views

2021 Expert Discussion on BC: How to Preoperatively Manage TNBC? How…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer, J. Litton, R. O’Regan

31 views

2021 Updates on Systemic Therapy for TNBC: Why Should We Choose Neoa…

3rd Annual Atlanta Precision Oncology Symposium

R. O’Regan

40 views

IO for mTNBC: Overview of the Efficacy Data

3rd Annual Atlanta Precision Oncology Symposium

J. Litton

345 views

ADCs & Targeted Therapies for Advanced TNBC: Can Sacituzumab Govitec…

3rd Annual Atlanta Precision Oncology Symposium

J. Litton

96 views

EGFR+ Advanced NSCLC: Should 1L Therapy Include an EGFR Inhibitor Re…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon

98 views

EGFR+ Advanced NSCLC: Efficacy Data of TKIs in Combination vs. Alone…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon

141 views

Sequence Algorithm for HER2+ Breast Cancer: Does Neratinib + Cape Ha…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

28 views

CNS Metastases in HER2+ MBC: PFS Data on the Addition of Tucatinib t…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

599 views

HER2+ MBC Sequencing Algorithm: Surveying the Data for Antibody-Drug…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

33 views

14:04

3rd Annual Atlanta Precision Oncology Symposium

[PRIVATE] Targeted Therapies for mRCC: Surveying Efficacy Data for I…

Feat. T. Zhang

17:05

3rd Annual Atlanta Precision Oncology Symposium

[PRIVATE] Targeted Therapies for mRCC: Assessing IMDC Risk Criteria …

Feat. T. Zhang

Targeting Genetic Mutations in mNSCLC: Clinical Data Overview of RET…

3rd Annual Atlanta Precision Oncology Symposium

H. Dilks

282 views